Semaglutide has gone off patent in India, cutting monthly costs to ₹3,000–₹5,000 from about ₹11,000 earlier, while higher prices continue in the US and Europe where patents remain active.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results